Cargando…

Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors

PURPOSE: The use of electronic patient-reported outcome (ePRO) data in routine care has been tied to direct patient benefits such as improved quality of care and symptom control and even overall survival. The modes of action behind such benefits are seldom described in detail. Here, we describe the...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva Lopes, André Manuel, Colomer-Lahiguera, Sara, Darnac, Célia, Giacomini, Stellio, Bugeia, Sébastien, Gutknecht, Garance, Spurrier-Bernard, Gilliosa, Aedo-Lopez, Veronica, Mederos, Nuria, Latifyan, Sofiya, Addedo, Alfredo, Michielin, Olivier, Eicher, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363070/
https://www.ncbi.nlm.nih.gov/pubmed/37480546
http://dx.doi.org/10.1007/s00520-023-07934-w
_version_ 1785076560953344000
author da Silva Lopes, André Manuel
Colomer-Lahiguera, Sara
Darnac, Célia
Giacomini, Stellio
Bugeia, Sébastien
Gutknecht, Garance
Spurrier-Bernard, Gilliosa
Aedo-Lopez, Veronica
Mederos, Nuria
Latifyan, Sofiya
Addedo, Alfredo
Michielin, Olivier
Eicher, Manuela
author_facet da Silva Lopes, André Manuel
Colomer-Lahiguera, Sara
Darnac, Célia
Giacomini, Stellio
Bugeia, Sébastien
Gutknecht, Garance
Spurrier-Bernard, Gilliosa
Aedo-Lopez, Veronica
Mederos, Nuria
Latifyan, Sofiya
Addedo, Alfredo
Michielin, Olivier
Eicher, Manuela
author_sort da Silva Lopes, André Manuel
collection PubMed
description PURPOSE: The use of electronic patient-reported outcome (ePRO) data in routine care has been tied to direct patient benefits such as improved quality of care and symptom control and even overall survival. The modes of action behind such benefits are seldom described in detail. Here, we describe the development of a model of care leveraging ePRO data to monitor and manage symptoms of patients treated with immune checkpoint inhibitors. METHODS: Development was split into four stages: (1) identification of an underlying theoretical framework, (2) the selection of an ePRO measure (ePROM), (3) the adaptation of an electronic application to collect ePRO data, and (4) the description of an ePRO-oriented workflow. The model of care is currently evaluated in a bicentric longitudinal randomized controlled phase II trial, the IePRO study. RESULTS: The IePRO model of care is grounded in the eHealth Enhanced Chronic Care Model. Patients are prompted to report symptoms using an electronic mobile application. Triage nurses are alerted, review the reported symptoms, and contact patients in case of a new or worsening symptom. Nurses use the UKONS 24-hour telephone triage tool to issue patient management recommendations to the oncology team. Adapted care coordinating procedures facilitate team collaboration and provide patients with timely feedback. CONCLUSION: This report clarifies how components of care are created and modified to leverage ePRO to enhance care. The model describes a workflow that enables care teams to be proactive and provide patients with timely, multidisciplinary support to manage symptoms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-023-07934-w.
format Online
Article
Text
id pubmed-10363070
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103630702023-07-24 Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors da Silva Lopes, André Manuel Colomer-Lahiguera, Sara Darnac, Célia Giacomini, Stellio Bugeia, Sébastien Gutknecht, Garance Spurrier-Bernard, Gilliosa Aedo-Lopez, Veronica Mederos, Nuria Latifyan, Sofiya Addedo, Alfredo Michielin, Olivier Eicher, Manuela Support Care Cancer Research PURPOSE: The use of electronic patient-reported outcome (ePRO) data in routine care has been tied to direct patient benefits such as improved quality of care and symptom control and even overall survival. The modes of action behind such benefits are seldom described in detail. Here, we describe the development of a model of care leveraging ePRO data to monitor and manage symptoms of patients treated with immune checkpoint inhibitors. METHODS: Development was split into four stages: (1) identification of an underlying theoretical framework, (2) the selection of an ePRO measure (ePROM), (3) the adaptation of an electronic application to collect ePRO data, and (4) the description of an ePRO-oriented workflow. The model of care is currently evaluated in a bicentric longitudinal randomized controlled phase II trial, the IePRO study. RESULTS: The IePRO model of care is grounded in the eHealth Enhanced Chronic Care Model. Patients are prompted to report symptoms using an electronic mobile application. Triage nurses are alerted, review the reported symptoms, and contact patients in case of a new or worsening symptom. Nurses use the UKONS 24-hour telephone triage tool to issue patient management recommendations to the oncology team. Adapted care coordinating procedures facilitate team collaboration and provide patients with timely feedback. CONCLUSION: This report clarifies how components of care are created and modified to leverage ePRO to enhance care. The model describes a workflow that enables care teams to be proactive and provide patients with timely, multidisciplinary support to manage symptoms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-023-07934-w. Springer Berlin Heidelberg 2023-07-22 2023 /pmc/articles/PMC10363070/ /pubmed/37480546 http://dx.doi.org/10.1007/s00520-023-07934-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
da Silva Lopes, André Manuel
Colomer-Lahiguera, Sara
Darnac, Célia
Giacomini, Stellio
Bugeia, Sébastien
Gutknecht, Garance
Spurrier-Bernard, Gilliosa
Aedo-Lopez, Veronica
Mederos, Nuria
Latifyan, Sofiya
Addedo, Alfredo
Michielin, Olivier
Eicher, Manuela
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
title Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
title_full Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
title_fullStr Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
title_full_unstemmed Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
title_short Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
title_sort development of an ehealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363070/
https://www.ncbi.nlm.nih.gov/pubmed/37480546
http://dx.doi.org/10.1007/s00520-023-07934-w
work_keys_str_mv AT dasilvalopesandremanuel developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT colomerlahiguerasara developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT darnaccelia developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT giacoministellio developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT bugeiasebastien developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT gutknechtgarance developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT spurrierbernardgilliosa developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT aedolopezveronica developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT mederosnuria developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT latifyansofiya developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT addedoalfredo developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT michielinolivier developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors
AT eichermanuela developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors